| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4002824 | American Journal of Ophthalmology | 2013 | 8 Pages |
Abstract
Aflibercept seems to be an effective alternative for neovascular age-related macular degeneration patients previously treated with bevacizumab, ranibizumab, or both at 4Â months of follow-up. Most treated eyes demonstrated stable visual acuity and anatomic improvements by spectral-domain optical coherence tomography.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Vincent Y. Ho, Steven Yeh, Timothy W. Olsen, Chris S. Bergstrom, Jiong Yan, Blaine E. Cribbs, G. Baker III,